Ivan Astralaga
Corporate Officer/Principal chez C-RAD AB
Fortune : 81 061 $ au 31/03/2024
Profil
Ivan Astralaga is currently the President-Americas at C-RAD AB since 2021.
Prior to this, he worked as the Vice President-Business Development & Sales at Mevion Medical Systems, Inc. from 2019 to 2021.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
C-RAD AB CLASS B
0,06% | 13/06/2023 | 20 204 ( 0,06% ) | 81 061 $ | 31/03/2024 |
Postes actifs de Ivan Astralaga
Sociétés | Poste | Début |
---|---|---|
C-RAD AB | Corporate Officer/Principal | 21/05/2021 |
Anciens postes connus de Ivan Astralaga
Sociétés | Poste | Fin |
---|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Sales & Marketing | 01/04/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
C-RAD AB | Health Technology |
Entreprise privées | 1 |
---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |